Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Sartorius
|
| gptkbp:acquisition |
acquired by Beckman Coulter
|
| gptkbp:awards |
received multiple innovation awards
recognized for technology advancements won best startup award |
| gptkbp:collaborations |
partnered with universities
partnered with government agencies partnered with private sector companies |
| gptkbp:focus |
improving viral research
|
| gptkbp:founded |
gptkb:2007
|
| gptkbp:founder |
gptkb:Dr._David_H._H._Hwang
|
| gptkbp:headquarters |
gptkb:Denver,_Colorado
|
| https://www.w3.org/2000/01/rdf-schema#label |
Viro Cyt
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:key_people |
gptkb:Dr._David_H._H._Hwang
Dr. John D. H. Hwang Dr. Michael J. H. Hwang |
| gptkbp:mission |
to enhance viral research capabilities
|
| gptkbp:partnership |
collaborated with various research institutions
|
| gptkbp:products |
Viro Cyt Virus Counter
Viro Cyt Virus Counter 2100 Viro Cyt Virus Counter 3100 Viro Cyt Virus Counter 4100 |
| gptkbp:research_focus |
viral load measurement
viral characterization viral quantification |
| gptkbp:services |
technical support
consulting services training services |
| gptkbp:specializes_in |
viral detection
|
| gptkbp:target_market |
clinical laboratories
pharmaceutical companies academic research institutions |
| gptkbp:technology |
flow cytometry
|
| gptkbp:values |
gptkb:collaboration
innovation integrity excellence customer focus |
| gptkbp:vision |
to be a leader in viral detection technology
|
| gptkbp:website |
www.virocyt.com
|